| Literature DB >> 32918669 |
Gary S Beasley1,2, Jeffrey A Towbin3,4.
Abstract
Cardiac mortality is the leading cause of death secondary to malignancy in survivors of cancer. The field of cardio-oncology is dedicated to identifying and, if possible, modifying risk factors that contribute to significant cardiac morbidity and mortality. Many risk factors for the development of cancer-related cardiotoxicity overlap with risk factors in cardiovascular disease such as hypertension, obesity, dyslipidemia, and diabetes among others. These risk factors are usually modifiable while others such as genetics, type of malignancy, and need for chemotherapy are less modifiable. This article summarizes acquired and modifiable risk factors in both pediatric and adult patients treated for cancer.Entities:
Keywords: Cancer; Cardio-oncology; Cardiovascular disease; Chemotherapy related cardiotoxicity
Mesh:
Substances:
Year: 2020 PMID: 32918669 DOI: 10.1007/s11239-020-02273-7
Source DB: PubMed Journal: J Thromb Thrombolysis ISSN: 0929-5305 Impact factor: 2.300